Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248310 · ClinicalTrials.gov registry record
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
A clinical trial of Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 600
- Enrollment target
- 3
- Study locations
NCT03248310: Recruiting study of Lymphedema, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03248310 is a study of Lymphedema that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 600 participants, below the 9,282-participant average among 34 other Lymphedema trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03248310, a study of Lymphedema, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
Primary Outcome
Questionnaire to assess quality of life changes
Conditions Studied
Interventions
- BEHAVIORAL Quality of Life Assessments
Study Locations (3)
New York
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites) - Rockville Centre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-08-09 |
| Est. Completion | 2026-08 |
What NCT03248310 shows while recruiting
NCT03248310 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 9,282-participant average among 34 other Lymphedema trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Quality of Life Assessments is the first listed.
NCT03248310 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03248310 about?
NCT03248310 is a clinical study titled "A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management". This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
What is the current status of trial NCT03248310?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2017-08-09. Estimated completion is 2026-08.
What conditions does trial NCT03248310 study?
This clinical trial studies the following conditions: Lymphedema.
What interventions are being tested in trial NCT03248310?
The interventions under investigation include: Quality of Life Assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT03248310?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03248310 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03248310's enrollment target sits among peer trials
600 4th of 34 higher than 31 of 34 other Lymphedema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphedema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphedema Surveillance Study
RECRUITING
-
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
RECRUITING · Early Phase 1
-
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
RECRUITING · Phase 2
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI